From the Journals News

Long-Term Follow-Up of Three First-Line Treatment Regimens in Mantle Cell Lymphoma

June 4, 2026
Share Share via Email Share on Facebook Share on LinkedIn Share on X
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.